Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-034621
Filing Date
2011-06-14
Accepted
2011-06-14 18:22:19
Documents
2
Period of Report
2011-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3991
2 POA DOCUMENT poa.txt EX-24.4_382589 3413
  Complete submission text file 0001209191-11-034621.txt   8719
Mailing Address 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063
Business Address 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 650-556-9300
GENOMIC HEALTH INC (Issuer) CIK: 0001131324 (see all company filings)

EIN.: 770552594 | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address AMYLIN PHARMACEUTICALS, INC. 885 ARAPAHOE AVENUE BOULDER CO 80302
Business Address
GRAHAM GINGER L (Reporting) CIK: 0001192601 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51541 | Film No.: 11911558